175 related articles for article (PubMed ID: 27781410)
1. Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers.
Zhou F; Xu Y; Shi J; Lan X; Zou X; Wang L; Huang Q
Cancer Med; 2016 Dec; 5(12):3403-3411. PubMed ID: 27781410
[TBL] [Abstract][Full Text] [Related]
2. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
[TBL] [Abstract][Full Text] [Related]
3. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis.
Mingchao ; Devereux TR; Stockton P; Sun K; Sills RC; Clayton N; Portier M; Flake G
Exp Toxicol Pathol; 2001 Sep; 53(4):237-46. PubMed ID: 11665847
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 mediated regulation of E-cadherin occurs in conventional but not early-onset gastric cancer cell lines.
Sitarz R; Leguit RJ; de Leng WW; Morsink FH; Polkowski WP; Maciejewski R; Offerhaus GJ; Milne AN
Cell Oncol; 2009; 31(6):475-85. PubMed ID: 19940363
[TBL] [Abstract][Full Text] [Related]
5. Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.
Guindalini RSC; Cormedi MCV; Maistro S; Pasini FS; Branas PCAA; Dos Santos L; de Lima Pereira GF; de Bock GH; Saccaro DM; Katayama MLH; Faraj SF; Safatle-Ribeiro A; Ribeiro Junior U; Diz MDPE; de Gouvêa ACRC; Chammas R; Folgueira MAAK
Gastric Cancer; 2019 Sep; 22(5):920-931. PubMed ID: 30895400
[TBL] [Abstract][Full Text] [Related]
6. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs.
Graziano F; Arduini F; Ruzzo A; Mandolesi A; Bearzi I; Silva R; Muretto P; Testa E; Mari D; Magnani M; Scartozzi M; Cascinu S
Ann Oncol; 2004 Mar; 15(3):489-92. PubMed ID: 14998854
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptors and androgen receptor and their clinical significance in gastric cancer.
Tang W; Liu R; Yan Y; Pan X; Wang M; Han X; Ren H; Zhang Z
Oncotarget; 2017 Jun; 8(25):40765-40777. PubMed ID: 28388558
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer.
Gamboa-Dominguez A; Seidl S; Reyes-Gutierrez E; Hermannstädter C; Quintanilla-Martinez L; Busch R; Höfler H; Fend F; Luber B
J Clin Pathol; 2007 Jul; 60(7):756-61. PubMed ID: 17483253
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
10. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions.
Herrera-Pariente C; Bonjoch L; Muñoz J; Fernàndez G; Soares de Lima Y; Mahmood R; Cuatrecasas M; Ocaña T; Lopez-Prades S; Llargués-Sistac G; Domínguez-Rovira X; Llach J; Luzko I; Díaz-Gay M; Lazaro C; Brunet J; Castillo-Manzano C; García-González MA; Lanas A; Carrillo M; Hernández San Gil R; Quintero E; Sala N; Llort G; Aguilera L; Carot L; Diez-Redondo P; Jover R; Ramon Y Cajal T; Cubiella J; Castells A; Balaguer F; Bujanda L; Castellví-Bel S; Moreira L
Gastric Cancer; 2024 Jul; 27(4):747-759. PubMed ID: 38796558
[TBL] [Abstract][Full Text] [Related]
11. Expression profile and prognostic role of sex hormone receptors in gastric cancer.
Gan L; He J; Zhang X; Zhang YJ; Yu GZ; Chen Y; Pan J; Wang JJ; Wang X
BMC Cancer; 2012 Dec; 12():566. PubMed ID: 23199240
[TBL] [Abstract][Full Text] [Related]
12. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
13. [Trends, challenges, and reflections on early-onset gastric cancer].
Wang XF; Sun YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):425-429. PubMed ID: 38778679
[TBL] [Abstract][Full Text] [Related]
14. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
[TBL] [Abstract][Full Text] [Related]
15. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
16. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer.
Shimada S; Mimata A; Sekine M; Mogushi K; Akiyama Y; Fukamachi H; Jonkers J; Tanaka H; Eishi Y; Yuasa Y
Gut; 2012 Mar; 61(3):344-53. PubMed ID: 21865403
[TBL] [Abstract][Full Text] [Related]
17. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
18. Downregulated Expression of E-cadherin and TP53 in Patients with Gastric Diseases: the Involvement of H. pylori Infection and Its Virulence Markers.
Ferraz MA; Zabaglia LM; Pereira WN; Orcini WA; de Labio RW; Caleman Neto A; Wisnieski F; Calcagno DQ; Santos LC; Assumpção PP; Burbano RR; Artigiani R; Smith Mde A; Payão SL; Rasmussen LT
J Gastrointest Cancer; 2016 Mar; 47(1):20-6. PubMed ID: 26585943
[TBL] [Abstract][Full Text] [Related]
19. Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.
Sereno M; De Castro J; Cejas P; García-Cabezas MA; Belda C; Casado E; Feliu J; Gómez C; López M; Barón MG
J Gastrointest Cancer; 2012 Jun; 43(2):181-9. PubMed ID: 21360269
[TBL] [Abstract][Full Text] [Related]
20. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):230-7. PubMed ID: 12966349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
